Free Trial

Curaleaf (OTCMKTS:CURLF) Trading 24% Higher - Still a Buy?

Curaleaf logo with Medical background

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) shares traded up 24% during trading on Monday . The company traded as high as $1.24 and last traded at $1.24. 678,026 shares were traded during trading, an increase of 23% from the average session volume of 551,082 shares. The stock had previously closed at $1.00.

Curaleaf Stock Performance

The stock has a 50-day simple moving average of $0.90 and a 200 day simple moving average of $1.05. The company has a debt-to-equity ratio of 1.08, a current ratio of 1.41 and a quick ratio of 0.70. The company has a market capitalization of $853.48 million, a PE ratio of -4.11 and a beta of 0.62.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported ($0.07) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.07). Curaleaf had a negative return on equity of 14.12% and a negative net margin of 17.37%. Equities analysts anticipate that Curaleaf Holdings, Inc. will post -0.25 EPS for the current fiscal year.

Curaleaf Company Profile

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Read More

Should You Invest $1,000 in Curaleaf Right Now?

Before you consider Curaleaf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.

While Curaleaf currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore
AI Stocks Are Printing Money — These 3 Are Just Getting Started

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines